phendimetrazine has been researched along with Obesity in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, AR; Yoon, YH | 1 |
| DiBartolomeo, JJ; Foreyt, JP; Haddock, CK; Poston, WS; Warner, PO | 1 |
| YOUNG, RE | 1 |
| HELLMAN, B; LARSSON, S; WESTMAN, S | 1 |
| RUNYAN, JW | 1 |
| LE RICHE, WH; VAN BELLE, G | 1 |
| Chang, JH; Chung, JK; Lee, W; Ohn, YH; Roh, KH | 1 |
| D'Agati, VD; Markowitz, GS; Tartini, A | 1 |
8 other study(ies) available for phendimetrazine and Obesity
| Article | Year |
|---|---|
Central Retinal Vein Occlusion Noted 2 Days After Use of Phendimetrazine as an Appetite Suppressant.
Topics: Acute Disease; Adult; Appetite Depressants; Bevacizumab; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Morpholines; Obesity; Radiography; Retinal Vein Occlusion; Severity of Illness Index; Treatment Outcome; Vision, Low; Visual Acuity | 2016 |
Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation.
Topics: Adult; Appetite Depressants; Body Mass Index; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Food, Formulated; Humans; Male; Morpholines; Obesity; Patient Dropouts; Phentermine; Weight Loss | 2008 |
Comparative study of phenmetrazine and phendimetrazine in the management of obesity.
Topics: Disease Management; Morpholines; Obesity; Phenmetrazine; Sympathomimetics | 1961 |
Acetate metabolism in isolated epididymal adipost tissue from obese-hyperglycemic mice of different ages.
Topics: Acetates; Adipose Tissue; Animals; Epididymis; Fatty Acids; Humans; Hypoglycemia; Lipid Metabolism; Male; Mice; Mice, Obese; Morpholines; Obesity | 1962 |
Observations on the use of phendimetrazine, a new anorexigenic agent, in obese diabetics.
Topics: Appetite; Diabetes Mellitus; Morpholines; Obesity; Sympathomimetics | 1962 |
Study of phendimetrazine bitartrate as an appetite suppressant in relation to dosage, weight loss and side effects.
Topics: Appetite; Appetite Depressants; Morpholines; Obesity; Sympathomimetics; Weight Loss | 1962 |
Anorexiant-induced transient myopia after myopic laser in situ keratomileusis.
Topics: Adult; Appetite Depressants; Atropine; Choroid; Ciliary Body; Humans; Keratomileusis, Laser In Situ; Male; Morpholines; Mydriatics; Myopia; Obesity; Tropicamide; Ultrasonography | 2007 |
Acute interstitial nephritis following treatment with anorectic agents phentermine and phendimetrazine.
Topics: Acute Disease; Anti-Inflammatory Agents; Appetite Depressants; Creatinine; Female; Follow-Up Studies; Glucocorticoids; Humans; Leukocytes; Methylprednisolone Hemisuccinate; Middle Aged; Morpholines; Nephritis, Interstitial; Obesity; Phentermine; Prednisone; Urine | 1998 |